Dataset Information


Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

ABSTRACT: RNA-guided engineered nucleases (RGENs) derived from the prokaryotic adaptive immune system known as CRISPR (clustered, regularly interspaced, short palindromic repeat)/Cas (CRISPR-associated) enable genome editing in human cell lines, animals, and plants, but are limited by off-target effects and unwanted integration of DNA segments derived from plasmids encoding Cas9 and guide RNA at both on-target and off-target sites in the genome. Here, we deliver purified recombinant Cas9 protein and guide RNA into cultured human cells including hard-to-transfect fibroblasts and pluripotent stem cells. RGEN ribonucleoproteins (RNPs) induce site-specific mutations at frequencies of up to 79%, while reducing off-target mutations associated with plasmid transfection at off-target sites that differ by one or two nucleotides from on-target sites. RGEN RNPs cleave chromosomal DNA almost immediately after delivery and are degraded rapidly in cells, reducing off-target effects. Furthermore, RNP delivery is less stressful to human embryonic stem cells, producing at least twofold more colonies than does plasmid transfection.


PROVIDER: S-EPMC4032847 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC3875854 | BioStudies
2014-01-01 | S-EPMC4021358 | BioStudies
2017-01-01 | S-EPMC5715146 | BioStudies
2015-01-01 | S-EPMC4282705 | BioStudies
2015-01-01 | S-EPMC4877446 | BioStudies
2015-01-01 | S-EPMC4469905 | BioStudies
2017-01-01 | S-EPMC5646780 | BioStudies
2018-01-01 | S-EPMC6230560 | BioStudies
2016-01-01 | S-EPMC4785396 | BioStudies
2016-01-01 | S-EPMC4920116 | BioStudies